Return to Statistics Toolbox

Volcano Plot analysis for Study ST002024

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Treatment:20190304-Blank (5)
Treatment:20190304-LipL2_AP_acetate (3)
Treatment:20190304-LipL2_AP_glucose (3)
Treatment:20190304-LipL2_AP_glutamine (3)
Treatment:20190304-QC (3)
Treatment:20190304-WT_AP_acetate (3)
Treatment:20190304-WT_AP_glucose (3)
Treatment:20190304-WT_AP_glutamine (3)
Treatment:20190313-Blank (5)
Treatment:20190313-LipL2_acetate (3)
Treatment:20190313-LipL2_glucose (3)
Treatment:20190313-LipL2_glutamine (3)
Treatment:20190313-QC (3)
Treatment:20190313-WT_acetate (3)
Treatment:20190313-WT_glucose (3)
Treatment:20190313-WT_glutamine (3)
Treatment:20190401-Blank (5)
Treatment:20190401-LipL2-glucose (3)
Treatment:20190401-LipL2-glutamine (3)
Treatment:20190401-QC (3)
Treatment:20190401-WT-glucose (3)
Treatment:20190401-WT-glutamine (3)
Treatment:20191107-BKE2_glucose (3)
Treatment:20191107-BKE2_glutamine (3)
Treatment:20191107-Blank (5)
Treatment:20191107-QC (3)
Treatment:20191107-WT_glucose (3)
Treatment:20191107-WT_glutamine (3)
Treatment:20191120-BKE2_glucose (3)
Treatment:20191120-BKE2_glutamine (3)
Treatment:20191120-Blank (5)
Treatment:20191120-QC (3)
Treatment:20191216-Blank (5)
Treatment:20191216-LipL2-glucose (3)
Treatment:20191216-LipL2-glutamine (3)
Treatment:20191216-QC (3)
Treatment:20191216-WT-glucose (3)
Treatment:20191216-WT-glutamine (3)
Treatment:20200810-BE12-Glucose-B1 (3)
Treatment:20200810-BE12-Glucose-B2 (3)
Treatment:20200810-BE12-Glutamine-B1 (3)
Treatment:20200810-BE12-Glutamine-B2 (3)
Treatment:20200810-Blank (5)
Treatment:20200810-QC (3)
P-value cutoff:    Fold-change cutoff:    Sample normalization:
Group by metabolite classification:    Use:
Maximum # of (most significant) metabolites per class to use in pvalue group calculation:
Analysis:Combine data for all analyses?:     

  logo